| Carolyn Bradley, | |
|
6401 A St, Anchorage, AK 99518-1824 | |
| (907) 355-3356 | |
| Not Available |
| Full Name | Carolyn Bradley |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 6401 A St, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023617230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carolyn Bradley, 6401 A St, Anchorage, AK 99518-1824 Ph: (907) 355-3356 | Carolyn Bradley, 6401 A St, Anchorage, AK 99518-1824 Ph: (907) 355-3356 |
News Archive
An international blood pressure study comparing two single-pill drug combinations has yielded results so significant that the study has been stopped early and the researchers say their findings might alter the way high blood pressure is treated worldwide.
Tenet Healthcare Corporation today reported adjusted EBITDA of $379 million for the first quarter ended March 31, 2011, an increase of $81 million, or 27.2 percent, compared to $298 million for the first quarter of 2010.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.
A federal judge Monday expressed skepticism that President Donald Trump's decision to halt certain health law insurance subsidies would cause consumers immediate harm, as California and many other states claim in a lawsuit.
› Verified 3 days ago
Mr. Duncan R Brooks, MS, LPC. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 E International Airport Rd Ste 100, Anchorage, AK 99518 Phone: 907-570-6382 Fax: 888-972-3679 | |
Carolyn Michaud, OTD OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 4325 Laurel St Ste 102, Anchorage, AK 99508 Phone: 907-569-5660 | |
Patricia Quinn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 741 Sesame St Ste 1b, Anchorage, AK 99503 Phone: 907-406-2642 | |
Mrs. Rebecca Ann Shestakov, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6952 Cutty Sark St, Anchorage, AK 99502 Phone: 907-982-5562 | |
Parinita Shetty, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7440 Creekside Center Dr, Anchorage, AK 99504 Phone: 907-279-9640 | |
Tau Vaaia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1709 Bragaw St, Anchorage, AK 99508 Phone: 907-562-5340 | |
Katie Ogin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2600 Cordova St, Anchorage, AK 99503 Phone: 907-279-9640 |